Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00303342 · ClinicalTrials.gov registry record · Phase 2
Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia
A Phase 2 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00303342 is a Phase 2 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 60 participants.
The verdict
NCT00303342, a Phase 2 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the change in measures of physiological arousal before and after behavioral treatment of insomnia.
Interventions
- BEHAVIORAL mind body treatment
- BEHAVIORAL desensitization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-03 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00303342
The ClinicalTrials.gov registry entry for NCT00303342 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which mind body treatment is the first listed.
NCT00303342 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00303342 about?
NCT00303342 is a clinical study titled "Neuroendocrine Mechanisms in Behavioral Treatment of Insomnia". The purpose of this study is to evaluate the change in measures of physiological arousal before and after behavioral treatment of insomnia.
What is the current status of trial NCT00303342?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-03. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00303342?
The interventions under investigation include: mind body treatment (BEHAVIORAL), desensitization (BEHAVIORAL).
Who is sponsoring clinical trial NCT00303342?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.